BDBM237687 US10052306, 233::rac-(3aR,5r,6aS)-5-(2,4- difluorobenzyl)-2-(2- hydroxy-2-(5- hydroxypyridin-2- yl)ethyl)octahydrocyclo- penta[c]pyrrol-5-ol

SMILES OC(CN1C[C@H]2C[C@](O)(Cc3ccc(F)cc3F)C[C@H]2C1)c1ccc(O)cn1

InChI Key InChIKey=VVIBJRKWDJTQAO-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 237687   

TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Cadent Therapeutics

US Patent
LigandPNGBDBM237687(rac-(3aR,5r,6aS)-5-(2,4- difluorobenzyl)-2-(2- hyd...)
Affinity DataIC50: 29.9nMAssay Description:To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
Go to US Patent